Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Progyny | PGNY | 1. avr 2025 | 23.09 | +3.36 |
ProKidney | PROK | 1. avr 2025 | 0.83 | -5.27 |
Prologis | PLD | 1. avr 2025 | 111.45 | -0.30 |
ProMIS Neurosciences | PMN | 1. avr 2025 | 0.75 | +8.54 |
ProPetro | PUMP | 1. avr 2025 | 7.54 | +2.59 |
ProPhase Labs | PRPH | 1. avr 2025 | 0.40 | -0.07 |
ProQR Therapeutics | PRQR | 1. avr 2025 | 1.29 | -3.01 |
PROS | PRO | 1. avr 2025 | 19.22 | +1.00 |
ProShares Bitcoin Strategy ETF | BITO | 1. avr 2025 | 18.49 | +0.93 |
Proshares Ultra FTSE Europe | UPV | 1. avr 2025 | 66.03 | +0.19 |
ProShares UltraShort Bloomberg Natural Gas | KOLD | 1. avr 2025 | 21.24 | +8.53 |
Proshares Ultrashort FTSE Europe | EPV | 1. avr 2025 | 33.59 | -0.12 |
Prospect Capital | PSEC | 1. avr 2025 | 4.06 | -0.98 |
Prospect Capital A Pref | PSEC-A | 1. avr 2025 | 16.25 | -0.49 |
Prosperity Bancshares | PB | 1. avr 2025 | 70.67 | -0.98 |
Protagenic Therapeutics | PTIX | 1. avr 2025 | 0.25 | +28.14 |
Protagonist Therapeutics | PTGX | 1. avr 2025 | 46.88 | -3.06 |
Protalix Bio Therapeutics | PLX | 1. avr 2025 | 2.54 | -0.78 |
Protara Therapeutics | TARA | 1. avr 2025 | 4.01 | -5.87 |
Prothena | PRTA | 1. avr 2025 | 11.74 | -5.13 |
Proto Labs | PRLB | 1. avr 2025 | 35.39 | +1.00 |
Provident Bancorp | PVBC | 1. avr 2025 | 11.49 | +0.09 |
Provident Financial | PROV | 1. avr 2025 | 14.51 | -0.55 |
Provident Financial Services | PFS | 1. avr 2025 | 17.19 | +0.12 |
Prudential ADR | PUK | 1. avr 2025 | 21.57 | +0.33 |
Prudential Financial | PRU | 1. avr 2025 | 111.69 | +0.01 |
Ps International Group | PSIG | 1. avr 2025 | 0.48 | +7.14 |
PSQ Holdings | PSQH | 1. avr 2025 | 2.20 | -3.93 |
Psyence Biomedical | PBM | 1. avr 2025 | 0.59 | -1.32 |
PT Telkom Indonesia (Persero) Tbk ADR | TLK | 1. avr 2025 | 14.87 | +0.68 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.